CellMEAT has raised ₩5 billion (approx. US$4.5 million) in a pre-Series A financing round that closed in late January 2021, the company has announced. The funding was led by South Korean private equity and venture capital firm NAU IB Capital, with participation from a number of domestic and international investors including BNK Venture Capital, DT & Investment, Ryu Kyung PSG Asset Management, JNU Holdings, Yonsei Technology Holdings, and Baltimore, U.S.-based firm Knollwood Investment Advisory.

Source: South Korean Startup CellMEAT Raises US$4.5M To Scale & Lower Cultured Meat Production Costs

By Grégory Maubon

Leading Innovation ++ on the Field ++ with a Purpose => I used AI in cultivated meat industry to optimize bioreactor design and to dramatically improve the efficiency and quality of production. I developed high quality 3D imagery process in a biotechnological startup to disrupt the drug discovery methods.

Leave a Reply

Your email address will not be published. Required fields are marked *